Today's post is by Em Walsh (McGill University).
The dominant view in the philosophical literature suggests that advance directives, documents which allow individuals to set out directions for their future medical care in the eventuality that they lose decisional capacity (de Boer et al 2010, 202), ought to hold decisive moral weight. Thus, defenders of this view such as, Ronald Dworkin (1994), Jeff McMahan (2005), and Govind Persad (2019) would maintain that the decision made in the case of Mrs Black was the correct one. The reason for this is that such views suggest documents such as advance directives reflect an individual’s judgements about their own lives and should therefore be given significant moral weight, even when the price of so doing is the life of the individual in question.
In my paper, "Cognitive Transformation, Dementia, and the Moral Weight of Advance Directives", I suggest that the dominant philosophical view does not best align with current clinical practice. In current clinical practice, clinician’s show great reluctance to implement advance directives which undermine the dementia patient’s overall well-being. I put forward a philosophical defence of current clinical practice which gives moral weight to the preferences of dementia patients after the onset of their disease. In particular, I use L.A. Paul’s transformative experience framework [Paul 2016] to argue that having dementia is a cognitive transformative experience and that preference changes which arise from this are legitimate and ought to be given moral-weight in medical decision-making.
This paper has been responded to by various bioethicists, clinicians, lawyers, and psychologists. These responses have also been published in the American Journal of Bioethics, and so too has my own response to these open peer commentaries. I invite those interested in the debate to email me if they have any comments or questions, as I would love to continue the dialogue on this issue further.